A meta-analysis from 2019 indicated that a 1 ng/mL elevation in baseline Gal-3 corresponded to a 17% higher risk of AF recurrence, independent of patient age, gender, and baseline LAD (RR = 1.17, 95%CI = 1.01‐1.35; p = 0.03) [4]. Here, LGALS3 is linked to atrial fibrillation.